Moors & Cabot
FBT icon

Moors & Cabot’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Moors & Cabot’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,517
Closed -$245K – 922
2025
Q2 		$245K Sell
1,517
-4,297
-74% -$684K 0.01% 721
2025
Q1 		$989K Sell
5,814
-5,047
-46% -$877K 0.05% 324
2024
Q4 		$1.81M Buy
10,861
+1,158
+12% +$198K 0.09% 201
2024
Q3 		$1.67M Buy
9,703
+374
+4% +$61.9K 0.08% 217
2024
Q2 		$1.44M Buy
9,329
+595
+7% +$89.3K 0.08% 230
2024
Q1 		$1.34M Buy
8,734
+365
+4% +$55.7K 0.07% 240
2023
Q4 		$1.32M Buy
8,369
+314
+4% +$45.1K 0.08% 234
2023
Q3 		$1.18M Buy
8,055
+264
+3% +$40.2K 0.08% 226
2023
Q2 		$1.19M Sell
7,791
-81
-1% -$12.6K 0.08% 240
2023
Q1 		$1.22M Sell
7,872
-41
-0.5% -$6.44K 0.08% 237
2022
Q4 		$1.22M Buy
7,913
+848
+12% +$125K 0.09% 237
2022
Q3 		$932K Buy
7,065
+109
+2% +$15.3K 0.07% 266
2022
Q2 		$943K Buy
6,956
+795
+13% +$110K 0.07% 283
2022
Q1 		$919K Buy
+6,161
New +$911K 0.06% 312
2018
Q2 		– Sell
-9,062
Closed -$1.2M – 570
2018
Q1 		$1.2M Buy
9,062
+1,845
+26% +$252K 0.16% 156
2017
Q4 		$896K Sell
7,217
-320
-4% -$39.5K 0.12% 201
2017
Q3 		$933K Buy
7,537
+167
+2% +$19.8K 0.13% 179
2017
Q2 		$841K Buy
7,370
+3,952
+116% +$425K 0.14% 186
2017
Q1 		$361K Sell
3,418
-3,195
-48% -$320K 0.06% 344
2016
Q4 		$600K Sell
6,613
-441
-6% -$41.3K 0.1% 244
2016
Q3 		$703K Sell
7,054
-3,299
-32% -$324K 0.12% 207
2016
Q2 		$927K Sell
10,353
-2,046
-17% -$188K 0.16% 156
2016
Q1 		$1.09M Sell
12,399
-540
-4% -$47.6K 0.2% 131
2015
Q4 		$1.46M Buy
+12,939
New +$1.39M 0.27% 102

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Berger Financial Group
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Moors & Cabot's FBT Position: Q3 2025 in Review

Moors & Cabot sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2025, closing a stake of 1,517 shares — an estimated $245K sold.

Moors & Cabot first reported a position in FBT in Q4 2015 and held it in 24 quarters. The position peaked at $1.81M in Q4 2024. 253 funds tracked by Wall St. Rank hold FBT as of Q3 2025.

  • Moors & Cabot reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2025 after selling out during the quarter.
  • Moors & Cabot sold 1,517 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2025, an estimated $245K.
  • Moors & Cabot first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2015 and held it in 24 quarters.
  • Moors & Cabot's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.81M in Q4 2024.
  • 253 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2025.

Based on Moors & Cabot's 13F filing for Q3 2025, filed 14 Nov 2025.